Subtle onset or changes in symptoms of ATTR-CM can indicate worsening heart failure. Learn how to track symptoms and when to seek medical attention.

In fact, among Medicare beneficiaries aged 65 years or older, the incidence of transthyretin cardiac amyloidosis (ATTR-CM) diagnoses rose from about 10.1 per 100,000 person-years ...

Hereditary ATTR-CM can run in families. Learn who may be at risk, when genetic testing is recommended, the benefits of screening, and how to talk with relatives.

Patients are now being identified earlier than ever, and new drugs approved by the FDA are prolonging their lives significantly.

DANVILLE, Pa. — Cardiac amyloidosis is a heart condition caused by protein buildup between the muscle cells of the heart. "Once it gets into the heart, it thickens the heart. It's not the muscle that ...

A type of heart failure caused by a build-up of amyloid can be accurately diagnosed and prognosticated with an imaging technique, eliminating the need for a biopsy, according to a multicenter study ...

A report from the World Heart Federation provides an overview of transthyretin amyloid cardiomyopathy (ATTR-CM), including tools for diagnosis and patient management, highlighting the importance of ...

A certain blood protein regarded as an early indicator of Alzheimer's disease also appears to play a role in other disorders.

MUNICH — Treatment with tafamidis (Vyndaqel, Pfizer) was associated with a reduction in all-cause mortality, as well as cardiovascular hospitalizations, and functional decline vs placebo in a new ...

These drugs reduce production of the abnormal transthyretin protein in the liver, which is responsible for many cases of cardiac amyloidosis. Doctors report that the medications have led to fewer ...

In this opening episode titled, ‘Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Clinical Burden and Diagnostic Challenges,’ moderator, Dr. Ryan Haumschild, and panelist, Dr. Kevin Alexander, ...